Normal view MARC view ISBD view

Bergstralh, Daniel T

Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. [electronic resource] - Cancer treatment reviews May 2006 - 166-79 p. digital

Publication Type: Journal Article; Review

ISSN: 0305-7372

Standard No.: 10.1016/j.ctrv.2006.01.004 doi

Subjects--Topical Terms:
Alkanes--pharmacology
Animals
Antineoplastic Agents--adverse effects
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Carbamates--pharmacology
Cyclooxygenase 2--metabolism
Diterpenes--pharmacology
Epothilones--pharmacology
Humans
Inhibitor of Apoptosis Proteins--metabolism
Interleukin-1--metabolism
Interleukin-8--metabolism
Lactones--pharmacology
MAP Kinase Kinase 1--metabolism
MAP Kinase Signaling System--drug effects
Macrolides
Maturation-Promoting Factor--metabolism
Microtubule-Associated Proteins--metabolism
Microtubules--drug effects
NF-kappa B--metabolism
Neoplasm Proteins--metabolism
Neoplasms--drug therapy
Phosphatidylinositol 3-Kinases--metabolism
Proto-Oncogene Proteins c-akt--metabolism
Pyrones--pharmacology
Signal Transduction--drug effects
Survivin
Taxoids--pharmacology
Tumor Suppressor Protein p53--metabolism